Difference between revisions of "Team:ETH Zurich"
| Line 23: | Line 23: | ||
$(target+'> h4').addClass('is-open'); | $(target+'> h4').addClass('is-open'); | ||
}); | }); | ||
| − | }); | + | }); |
</script> | </script> | ||
| Line 32: | Line 32: | ||
e.preventDefault(); | e.preventDefault(); | ||
$('html, body').animate({ scrollTop: $($(this).attr('href')).offset().top}, 500, 'linear'); | $('html, body').animate({ scrollTop: $($(this).attr('href')).offset().top}, 500, 'linear'); | ||
| − | + | }); | |
| − | + | }); | |
</script> | </script> | ||
| Line 97: | Line 97: | ||
<div class="title"> | <div class="title"> | ||
| − | <center> | + | <center> |
| − | + | <a href="https://2017.igem.org/Team:ETH_Zurich"> | |
| − | + | <img src="https://static.igem.org/mediawiki/2017/c/c3/T--ETH_Zurich--Banner.png" width="900px"> | |
| − | + | </a> | |
| − | <center> | + | <center> |
</div> | </div> | ||
| Line 107: | Line 107: | ||
<center> | <center> | ||
<a href="#start"> | <a href="#start"> | ||
| − | + | <img src="https://static.igem.org/mediawiki/2017/1/14/T--ETH_Zurich--Scroll.png" width="70px"> | |
| − | + | </a> | |
</center> | </center> | ||
<div class="content"> | <div class="content"> | ||
| − | <div id="start"> | + | <div id="start"> |
| − | + | Cancer kills over 8 million people every year. That's the entire population of Switzerland! <br><br> | |
| − | + | We need more specific therapies because current approaches result in many side-effects.<br> | |
| − | + | That's why we created CATE: Cancer-Targeting E. coli. | |
| − | + | <br> | |
| − | + | <br> | |
| − | + | <a href="https://2017.igem.org/Team:ETH_Zurich/Background" class="more">Learn more</a> | |
| − | + | <img src="https://static.igem.org/mediawiki/2017/9/99/T--ETH_Zurich--CH.png" class="CH" width="500px" align="right"> | |
| − | + | </div> | |
| − | </div> | + | |
| − | <div id="second"> | + | <div id="second"> |
| − | + | <img src="https://static.igem.org/mediawiki/2017/0/02/T--ETH_Zurich--Ec.png" class="Ec" width="400px" align="left"> | |
| − | + | ||
| − | + | CATE consists of the non-pathogenic bacterium E. coli Nissle that has the intrinsic ability to home specifically in tumors.<br><br> We are engineering E. coli Nissle to carry a MRI | |
| − | + | contrast and a cytotoxic agent so it can deliver both components to tumor sites. | |
| − | + | <br> | |
| − | + | <br> | |
| − | + | <a href="https://2017.igem.org/Team:ETH_Zurich/Description" class="more">Project description</a> | |
</div> | </div> | ||
Revision as of 14:46, 7 October 2017
Cancer kills over 8 million people every year. That's the entire population of Switzerland!
We need more specific therapies because current approaches result in many side-effects.
That's why we created CATE: Cancer-Targeting E. coli.
Learn more
We need more specific therapies because current approaches result in many side-effects.
That's why we created CATE: Cancer-Targeting E. coli.
Learn more
CATE consists of the non-pathogenic bacterium E. coli Nissle that has the intrinsic ability to home specifically in tumors.We are engineering E. coli Nissle to carry a MRI contrast and a cytotoxic agent so it can deliver both components to tumor sites.
Project description
